Gulf International Bank (Uk) LTD Seagen Inc. Transaction History

Gulf International Bank (Uk) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$191.51 - $216.16 $277,497 - $313,215	-1,449 Reduced 10.18%	12,781 $2.71 Million
Q2 2023 Aug 02, 2023	SELL	$187.64 - $206.25 $745,118 - $819,018	-3,971 Reduced 21.82%	14,230 $2.74 Million
Q1 2023 Apr 12, 2023	SELL	$127.59 - $203.08 $119,551 - $190,285	-937 Reduced 4.9%	18,201 $3.69 Million
Q4 2021 Jan 24, 2022	BUY	$142.57 - $190.86 $2.73 Million - $3.65 Million	19,138 New	19,138 $2.96 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.